Home > NRC Library > ADAMS Public Documents
06-30726-01 611649 Melinta Therapeutics, Inc. (Term.)
Accession Number: ML19084A113
Date Released: Monday, April 29, 2019
Package Contents
The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.
- ML19105B276 - Melinta Therapeutics, Inc.; Deficiency Response Letter dtd April 8, 2019; Control No. 611649. (1 page(s), 4/8/2019)
- ML19106A371 - Melinta Therapeutics, Inc.; Telephone Conversation Record dtd 4/4/2019 RE: Deficiency Request; Control No. 611649. (1 page(s), 4/4/2019)
- ML19109A237 - Melinta Therapeutics, Inc.; Cover Letter dtd April 10, 2019, for License Termination, License Amendment No. 6; Control No. 611649. (3 page(s), 4/10/2019)
- ML19109A242 - Melinta Therapeutics, Inc.; License Termination, License Amendment No. 6; Control No. 611649. (1 page(s), 4/10/2019)